Press Release Archives

Press Release

Genovac Enters Exclusive Licensing Agreement with Pfizer for Therapeutic Antibody Candidates

Pfizer to obtain exclusive worldwide rights to develop and commercialize antibodies from Genovac academic collaboration Fargo, North Dakota, USA, September…

September 19, 2023

View

Press Release

Public-Private Collaboration Takes Aim at Hard-to-Target Cancers

Fargo, N.D., USA (3/13/2023) – Genovac, a Fargo based contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures…

March 13, 2023

View

Press Release

Genovac further enhances its antibody discovery services with the ENPICOM IGX Platform

Genovac will use ENPICOM’s world-leading cloud platform to accelerate and improve antibody discovery and early de-risking of development for clients.

May 2, 2022

View

Press Release

Genovac Acquires the Carterra LSA^® Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services

Genovac becomes Carterra’s 100th LSA placement throughout the world. Fargo, North Dakota and Salt Lake City, Utah — April 20,…

April 20, 2022

View

Press Release

Genovac to Present Innovations in Antibody Discovery Against Challenging Targets at Festival of Biologics in San Diego, March 9-11

Fargo, North Dakota, Mar 7, 2022 — Genovac, a contract research and manufacturing organization specializing in antibody discovery against challenging…

March 8, 2022

View

Press Release

Genovac to Present Latest Innovations in Antibody Discovery Against Difficult Targets at Antibody Engineering & Therapeutics Conference in San Diego

Fargo, North Dakota, Dec. 13, 2021 — Genovac, a contract research and manufacturing organization specializing in antibody discovery against challenging…